标题
Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease
作者
关键词
-
出版物
CLINICAL SCIENCE
Volume 124, Issue 1, Pages 17-26
出版商
Portland Press Ltd.
发表日期
2012-09-07
DOI
10.1042/cs20120167
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Glucagon-like Peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation
- (2013) Xie Xiao-Yun et al. MEDICAL SCIENCE MONITOR
- Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease
- (2012) Ai-li Sun et al. Diabetes & Vascular Disease Research
- Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
- (2012) D. Nathanson et al. DIABETOLOGIA
- The Role of High-Mobility Group Box-1 Protein in the Development of Diabetic Nephropathy
- (2011) Junghyun Kim et al. AMERICAN JOURNAL OF NEPHROLOGY
- Renal Function in Diabetic Disease Models: The Tubular System in the Pathophysiology of the Diabetic Kidney
- (2011) Volker Vallon et al. Annual Review of Physiology
- Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
- (2011) Sridevi Devaraj et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury
- (2011) Hiromasa Goto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel aspects of cellular action of dipeptidyl peptidase IV/CD26
- (2011) Siegfried Ansorge et al. BIOLOGICAL CHEMISTRY
- Clinical Pharmacology of Incretin Therapies for Type 2 Diabetes Mellitus: Implications for Treatment
- (2011) Joshua J. Neumiller CLINICAL THERAPEUTICS
- High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
- (2011) C. Marchetti et al. DIABETOLOGIA
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
- (2011) Jacob Lønborg et al. EUROPEAN HEART JOURNAL
- HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
- (2011) José Augusto Nogueira-Machado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice
- (2011) Nga N Ta et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
- (2011) M. Lin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glucagon-like peptide–1 suppresses advanced glycation end product–induced monocyte chemoattractant protein–1 expression in mesangial cells by reducing advanced glycation end product receptor level
- (2011) Yuji Ishibashi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- ABSTRACTS DAY 2
- (2011) NEPHROLOGY
- Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways
- (2011) Zubair Shah et al. VASCULAR PHARMACOLOGY
- Peptidomics of the Prolyl Peptidases
- (2010) Anna Mari Lone et al. AAPS Journal
- Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
- (2010) Pantelis A. Sarafidis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renoprotection by Rosiglitazone in Accelerated Type 2 Diabetic Nephropathy: Role of STAT1 Inhibition and Nephrin Restoration
- (2010) Sydney C.W. Tang et al. AMERICAN JOURNAL OF NEPHROLOGY
- DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
- (2010) Nga N. Ta et al. ATHEROSCLEROSIS
- Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines
- (2010) Wataru Takasawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats
- (2010) Que Liu et al. Cardiovascular Diabetology
- DPP-4 Inhibition by Sitagliptin Improves the Myocardial Response to Dobutamine Stress and Mitigates Stunning in a Pilot Study of Patients With Coronary Artery Disease
- (2010) Philip A. Read et al. Circulation-Cardiovascular Imaging
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1
- (2010) G. P. Fadini et al. DIABETES CARE
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Potential manipulation of endothelial progenitor cells in diabetes and its complications
- (2010) G. P. Fadini et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
- (2010) P. Anagnostis et al. DIABETES OBESITY & METABOLISM
- Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes
- (2010) Seung Jin Han et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- HMGB1 Contributes to Kidney Ischemia Reperfusion Injury
- (2010) H. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy
- (2010) Sally A. Penfold et al. KIDNEY INTERNATIONAL
- High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy
- (2010) Yoko Oyama et al. LABORATORY INVESTIGATION
- Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
- (2010) Ö. Erdogdu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The evolving place of incretin-based therapies in type 2 diabetes
- (2010) Baptist Gallwitz PEDIATRIC NEPHROLOGY
- Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model
- (2009) Kunio Hirata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
- (2009) Leo Timmers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies
- (2009) Kiwon Ban et al. Journal of the American Society of Hypertension
- Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
- (2008) Judy R. van Beijnum et al. ANGIOGENESIS
- Hypoxia-Inducible Factor-1 Target Genes as Indicators of Tumor Vessel Response to Vascular Endothelial Growth Factor Inhibition
- (2008) D. T. Dang et al. CANCER RESEARCH
- Peptidase substrates via global peptide profiling
- (2008) Debarati M Tagore et al. Nature Chemical Biology
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Decreased dipeptidyl peptidase-IV activity and glucagon-like peptide-1(7-36)amide degradation in type 2 diabetic subjects
- (2007) Aine M. McKillop et al. DIABETES RESEARCH AND CLINICAL PRACTICE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More